(EMHC) Bloomberg Barclays Emerging - Overview
Etf: Dollar-Denominated Sovereign, Quasi-Sovereign, Corporate Debt
Dividends
| Dividend Yield | 6.80% |
| Yield on Cost 5y | 6.74% |
| Yield CAGR 5y | 15.39% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 3.93% |
| Relative Tail Risk | -0.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.24 |
| Alpha | 5.44 |
| Character TTM | |
|---|---|
| Beta | 0.223 |
| Beta Downside | 0.227 |
| Drawdowns 3y | |
|---|---|
| Max DD | 7.67% |
| CAGR/Max DD | 1.15 |
Description: EMHC Bloomberg Barclays Emerging January 02, 2026
EMHC is a U.S.-registered ETF that commits at least 80% of its assets to securities that either belong to its benchmark index or have economic characteristics deemed substantially identical to those index constituents. Because it is classified as non-diversified, the fund can concentrate holdings in a relatively small number of issuers, which may amplify both return potential and idiosyncratic risk.
As of the latest filing, EMHC manages roughly $2.5 billion in assets, with an average portfolio duration of about 5.5 years and a weighted-average credit rating near B+. The fund’s exposure is heavily weighted toward sovereign debt from emerging-market governments, especially those issuing USD-denominated bonds, making the USD-exchange rate and global interest-rate policy key drivers of performance.
For a deeper quantitative breakdown of EMHC’s risk-return profile, you might explore the analytics on ValueRay.
What is the price of EMHC shares?
Over the past week, the price has changed by +0.61%, over one month by +0.98%, over three months by +1.73% and over the past year by +12.61%.
Is EMHC a buy, sell or hold?
What are the forecasts/targets for the EMHC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 28.5 | 11.4% |
EMHC Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 239.4m USD (239.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 239.4m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 239.4m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.74% (E(239.4m)/V(239.4m) * Re(6.74%) + (debt-free company))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)